This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clouse, W D. Articles by Miller, V. M Search for Related Content PubMed PubMed Citation Articles by Clouse, W D. Articles by Miller, V. M Social Bookmarking                   What's this?

Short-term treatment with transdermal nicotine affects the function of canine saphenous veins

Department of Center Surgery, Mayo Clinic and Foundation, Rochester, MN, USA, Department of Center Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA, Wilford Hall Medical Center, Department of Surgery, 59th MDW/MMKG, 2200 Bergquist Avenue, Suite 1, Lackland, AFB 78236-5300, USA

Kevin S Rud

Department of Center Surgery, Mayo Clinic and Foundation, Rochester, MN, USA

Richard D Hurt

Department of Center Internal Medicine, Mayo Clinic and Foundation, Rochester, MN, USA, Department of Center Nicotine Research, Mayo Clinic and Foundation, Rochester, MN, USA

Virginia M Miller

Department of Center Surgery, Mayo Clinic and Foundation, Rochester, MN, USA, Physiology and Biophysics, Mayo Clinic and Foundation, Rochester, MN, USA

Experiments were designed to determine the effects of nicotine treatment on the functions of saphenous veins used for coronary artery bypass grafts in dogs. Dogs received either no treatment or transdermal nicotine for 5 weeks at doses of 11 mg, 22 mg or 44 mg/day. Saphenous veins were removed and suspended for the measurement of isometric force in organ chambers. Endothelium was removed mechanically from some rings. N^G-mono-methyl-l-arginine (l-NMMA; 10^-4 M) was used to inhibit the production of nitric oxide. Contractions to alpha₂-adrenergic stimulation were decreased in veins from dogs treated with a 22-mg/day dose of transdermal nicotine. In addition, endothelium-dependent relaxations to adenosinediphosphate (10^-8-10^-4 M) and the calcium ionophore A23,187 (10^-8-10^-6 M) were decreased in veins from dogs with a 22-mg/day dose and increased in veins from dogs treated with a 44-mg/day dose. These relaxations were inhibited by l-NMMA. Plasma concentrations of oxidized products of nitric oxide were decreased only in dogs treated with 22 mg/day of nicotine. The relaxation of rings without endothelium (direct response on the smooth muscle) to nitric oxide were not altered by nicotine treatment. These results suggest that the short-term treatment of dogs with intermediate (22 mg/day) but not low (11 mg/day) or high (44 mg/day) doses of transdermal nicotine decreases the endothelial function of veins used for coronary artery bypass grafts. Therefore, changes in plasma products of nitric oxide and endothelium-depen-dent relaxations mediated by nitric oxide are related to the dose of nicotine treatment.

Key Words: adenosine diphosphate • cotinine • endothelium • nitric oxide • smooth muscle • thrombin

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. P. Moyer, J. R. Charlson, R. J. Enger, L. C. Dale, J. O. Ebbert, D. R. Schroeder, and R. D. Hurt Simultaneous Analysis of Nicotine, Nicotine Metabolites, and Tobacco Alkaloids in Serum or Urine by Tandem Mass Spectrometry, with Clinically Relevant Metabolic Profiles Clin. Chem., September 1, 2002; 48(9): 1460 - 1471. [Abstract] [Full Text] [PDF]

				B. H. Tonnessen, S. R. Severson, R. D. Hurt, and V. M. Miller Modulation of Nitric-Oxide Synthase by Nicotine J. Pharmacol. Exp. Ther., November 1, 2000; 295(2): 601 - 606. [Abstract] [Full Text]

				V. M. Miller, W. D. Clouse, B. H. Tonnessen, U. S. Boston, S. R. Severson, S. Bonde, K. S. Rud, and R. D. Hurt Time and dose effect of transdermal nicotine on endothelial function Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1913 - H1921. [Abstract] [Full Text] [PDF]